Resource Articles

Expert Advice: Opportunities for Laboratories to Improve Patient Outcomes

Share this Article:

Tumor Profiling Expert AdviceRecent advancements in cancer genetics and the rise of targeted therapies, solid tumor profiling has proven essential in determining the most effective treatment options for patients. As molecular pathology labs test more genomic targets, Dr. Darryl Irwin, Vice President of Scientific Affairs at Agena Bioscience®, shares how labs can use these opportunities to improve cancer treatment while maintaining high-quality customer results.

Download the PDF:

Three Opportunities for Labs to Lead Improvements in Cancer Treatment